WAZIR, N.; REHMAN, S. U. Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus. Journal of Gandhara Medical and Dental Science, [S. l.], v. 9, n. 1, p. 24–27, 2022. DOI: 10.37762/jgmds.9-1.173. Disponível em: http://jgmds.org.pk/index.php/JGMDS/article/view/173. Acesso em: 18 sep. 2024.